AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10838017
Drug: Ivabradine (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivabradine (multiple dose oral administration every 12 h, eight active dosing levels)
Trial: 3766413
Drug: Isosorbide 5‐mononitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide 5‐mononitrate (IS 5‐MN), 40 mg twice daily
Trial: 3399285
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose intravenous gamma-globulin (0.6 g/kg every 4 weeks)
Trial: 3399285
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose intravenous gamma-globulin
Trial: 3399285
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose therapy (not specified in detail)
Trial: 31642434
Drug: Calorie-enriched formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calorie-enriched formula milk powder (100 kcal/100 mL)
Trial: 31642434
Drug: Normal calorie
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal calorie formula milk powder (67 kcal/100 mL)
Trial: 24009294
Drug: ACE inhibitors
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors and ARBs (continuation regimen)
Trial: 9575601
Drug: Picotamide, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picotamide, 300 mg t.i.d.
Trial: 3049173
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% fenticonazole cream
Trial: 3709210
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% miconazole cream
Trial: 30477828
Drug: Reminiscence therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reminiscence therapy applied through individual sessions for 8 weeks, with house visits once a week.
Trial: 22776634
Drug: Lurasidone 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone 160 mg/d
Trial: 24743712
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR 600 mg/d
Trial: 22544016
Drug: Escitalopram 20
RxNorm normalized name: escitalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 20 mg (started at 10 mg/d, increased to 20 mg/d after 4 weeks)
Trial: 15997019
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cognitive-behavioral therapy and fluoxetine hydrochloride
Trial: 12622581
Drug: Invasive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Invasive therapy (coronary angiography followed by revascularization if feasible)
Trial: 11138536
Drug: Tea ointment
RxNorm normalized name: tea tree oil Topical Ointment
DrugBank: Tea leaf (DB10580)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea ointment
Trial: 9178345
Drug: Biofeedback treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback treatment (once a week for a total of four sessions)
Trial: 9178345
Drug: Biofeedback treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback treatment (after self-monitoring control period)
Trial: 3620275
Drug: Isoxicam, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoxicam, 200 mg once daily
Trial: 3620275
Drug: Ketoprofen, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen, 100 mg three times daily
Trial: 18311688
Drug: Citalopram (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (0.4 mg/kg body weight, mean 31.96±4.45 mg)
Trial: 9084545
Drug: Furosemide 30
RxNorm normalized name: furosemide 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 30 mg i.v.
Trial: 9084545
Drug: Glycerol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol 0.5 g/kg i.v.
Trial: 30822621
Drug: Docetaxel 100
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 100 mg/m2 + Sorafenib 400 mg bid
Trial: 30822621
Drug: Docetaxel 100
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 100 mg/m2 + Placebo
Trial: 28946838
Drug: Single 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 5 ml GO-ON injection
Trial: 28946838
Drug: Conventional three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional three injections of 2.5 ml GO-ON at weekly intervals
Trial: 22394648
Drug: Inhaled budesonide/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide/formoterol (200 μg/12 μg)
Trial: 22394648
Drug: Inhaled budesonide/salbutamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide/salbutamol (200 μg/200 μg)
Trial: 21562990
Drug: Medication review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication review
Trial: 17537096
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication review
Trial: 9701099
Drug: 14-day triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day triple therapy (30 mg of lansoprazole, 1 g of amoxicillin, and 500 mg of clarithromycin twice daily for 14 days)
Trial: 9701099
Drug: 10-day triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day triple therapy (30 mg of lansoprazole, 1 g of amoxicillin, and 500 mg of clarithromycin twice daily for 10 days)
Trial: 9701099
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events related to therapy in 14-day group
Trial: 9701099
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events related to therapy in 10-day group
Trial: 2224165
Drug: IL2 alone
RxNorm normalized name: DAB(SUB 389)IL2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL2 alone or in combination with LAK cells, INF alpha or TNF
Trial: 2224165
Drug: IL2 either
RxNorm normalized name: 2,2',3,3',4,4',5,5',6-nonachlorodiphenyl either
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL2 either alone or in combination with LAK cells
Trial: 445326
Drug: Combination chemotherapy-radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy-radiotherapy (CT)
Trial: 445326
Drug: Combination chemotherapy-radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy-radiotherapy with radiation to involved fields (CTIF)
Trial: 445326
Drug: Combination chemotherapy-radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy-radiotherapy with total nodal radiation (CTTN)
Trial: 445326
Drug: Total nodal
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total nodal radiation followed by chemotherapy (TNCT)
Trial: 445326
Drug: Radiation +/−
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation +/− chemotherapy
Trial: 25927657
Drug: GlideScope (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GlideScope (group G, n=35)
Trial: 25927657
Drug: GlideScope (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GlideScope (group G)
Trial: 21981988
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin treatment (Control)
Trial: 21953205
Drug: Medications for
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medications for the treatment of fibromyalgia (specific medications not detailed)
Trial: 19217105
Drug: Abdominal massage
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abdominal massage in addition to prescribed laxatives
Trial: 19217105
Drug: Laxatives according
RxNorm normalized name: clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Laxatives according to earlier prescriptions
Trial: 17441849
Drug: Povidone iodine
RxNorm normalized name: POVIDONE IODINE
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone iodine (PVP‐I) 100 mg/ml
Trial: 17441849
Drug: Povidone iodine
RxNorm normalized name: POVIDONE IODINE
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone iodine (PVP‐I) 70 mg/ml
Trial: 17441849
Drug: Chlorhexidine digluconate
RxNorm normalized name: Chlorhexidine digluconate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine digluconate 50 mg/ml
Trial: 15604328
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg/day for 4 weeks
Trial: 7711988
Drug: Simvastatin 10-20
RxNorm normalized name: ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Simvastatin 10-20 mg
Trial: 2791449
Drug: Oral verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral verapamil (120 mg) and propranolol (80 mg) combined
Trial: 3092851
Drug: Oral verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral verapamil (120 mg)
Trial: 24203262
Drug: Oral propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propranolol (80 mg)
Trial: 780040
Drug: Ethosuximide given
RxNorm normalized name: Ethosuximide
DrugBank: Ethosuximide (DB00593)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethosuximide given once daily
Trial: 780040
Drug: Ethosuximide given
RxNorm normalized name: Ethosuximide
DrugBank: Ethosuximide (DB00593)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethosuximide given 3 times daily
Trial: 780040
Drug: Single daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single daily dose regimen
Trial: 28789780
Drug: IncobotulinumtoxinA (IncoA)
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: IncobotulinumtoxinA (IncoA) injection
Trial: 23930743
Drug: Escitalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (10 mg for patients ≤65 years; 5 mg for patients >65 years)
Trial: 23930743
Drug: Problem-solving therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-solving therapy (PST, 12 total sessions)
Trial: 16982785
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg extended-release ciprofloxacin
Trial: 11377154
Drug: Propofol 6
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 6 microg/mL
Trial: 11377154
Drug: Propofol 8
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 8 microg/mL
Trial: 8566633
Drug: etodolac 400
RxNorm normalized name: etodolac 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etodolac 400 mg
Trial: 2598769
Drug: Ursodiol 250
RxNorm normalized name: ursodiol 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodiol 250 mg/day
Trial: 2598769
Drug: Ursodiol 500
RxNorm normalized name: ursodiol 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodiol 500 mg/day
Trial: 2598769
Drug: Ursodiol 750
RxNorm normalized name: ursodeoxycholate
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodiol 750 mg/day
Trial: 2598769
Drug: Ursodiol administration
RxNorm normalized name: ursodeoxycholate
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodiol administration in patients with initial serum bilirubin levels > 2 mg/dl
Trial: 28486043
Drug: Azacitidine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azacitidine (75 mg/m2/day on days 1 to 7 of a 28-day cycle)
Trial: 28486043
Drug: Azacitidine plus
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine plus Lenalidomide (10 mg/day on days 1 to 21)
Trial: 28486043
Drug: Azacitidine plus
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine plus Vorinostat (300 mg twice daily on days 3 to 9)
Trial: 16986136
Drug: Intravesical instillation
RxNorm normalized name: ADSTILADRIN Suspension for Intravesical Instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical instillation of 100 ml capsaicin diluted in glucidic solvent (CG)
Trial: 16455629
Drug: 89SrCl2 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 89SrCl2 therapy
Trial: 12701977
Drug: Cisplatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (40 mg/m2) concurrent with radiotherapy
Trial: 11013775
Drug: Morphine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (5 mg) injected periarticularly
Trial: 8805740
Drug: Adenosine (0.140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine (0.140 mg/kg/min for 6 minutes)
Trial: 8805740
Drug: Dipyridamole (0.142
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (0.142 mg/kg/min for 4 minutes)
Trial: 1621888
Drug: Proguanil (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proguanil (200 mg/day) combined with dapsone (4 mg or 12.5 mg/day)
Trial: 1621888
Drug: Pyrimethamine/dapsone (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrimethamine/dapsone (12.5 mg and 100 mg/week)
Trial: 6150856
Drug: S3341 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S3341 (2 mg)
Trial: 2883104
Drug: Clonidine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.1 and 0.2 mg)
Trial: 19731013
Drug: Exemestane 25
RxNorm normalized name: exemestane 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane 25 mg for 8 weeks
Trial: 19731013
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg for 8 weeks
Trial: 17606534
Drug: Oral, attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral, attenuated monovalent G1[P8] human rotavirus vaccine (10^4.7 infectious units)
Trial: 17606534
Drug: Oral, attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral, attenuated monovalent G1[P8] human rotavirus vaccine (10^5.2 infectious units)
Trial: 17606534
Drug: Oral, attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral, attenuated monovalent G1[P8] human rotavirus vaccine (10^5.8 infectious units)
Trial: 7774139
Drug: Intrapartum antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapartum antibiotics (group 1)
Trial: 2321774
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl (100 micrograms in 10 ml normal saline)
Trial: 2321774
Drug: Epidural normal
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural normal saline (10 ml)
Trial: 2321774
Drug: Epidural catheter
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural catheter with no solution injected
Trial: 7359263
Drug: 7 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 mg/kg hydrocortisone intravenously every six hours
Trial: 7359263
Drug: Salbutamol inhalations
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol inhalations and intravenous aminophylline therapy (common to both groups)
Trial: 30670044
Drug: Remote cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remote cognitive behaviour therapy (RCBT)
Trial: 28644208
Drug: Whole Body
RxNorm normalized name: MaxiVision Whole Body Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole Body Vibration (WBV) during therapy sessions (S1, S2, S3) consisting of five upper and/or lower extremity exercises.
Trial: 28644208
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard therapy alone) during therapy sessions (S1, S2, S3).
Trial: 23982478
Drug: Intramyocardial injection
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRAEPICARDIAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells (MSC)
Trial: 30484987
Drug: Care Notebook
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Care Notebook intervention (self-monitoring QOL), completed once daily.
Trial: 27876083
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment and usual care
Trial: 27876083
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care without endovascular treatment
Trial: 25050340
Drug: Fosaprepitant 150
RxNorm normalized name: fosaprepitant 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosaprepitant 150 mg i.v. (NK1 group)
Trial: 25050340
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg i.v. (ONS group)
Trial: 22207026
Drug: Subacromial patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subacromial patient-controlled analgesia (SA-PCA) with 0.5% ropivacaine at a rate of 2 ml/h and a patient-controlled bolus dose of 2 ml.
Trial: 22207026
Drug: Intravenous patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled analgesia (IV-PCA).
Trial: 19633051
Drug: Chemoendocrine adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoendocrine adjuvant therapy without goserelin in premenopausal patients with endocrine-responsive tumors
Trial: 19633051
Drug: Adequate endocrine
RxNorm normalized name: Adequan
DrugBank: Polysulfated glycosaminoglycan (DB11538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adequate endocrine adjuvant therapy
Trial: 16881941
Drug: Standard depression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard depression treatment plus literacy education
Trial: 16881941
Drug: Standard depression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard depression treatment
Trial: 3884152
Drug: 200 mg/m2/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/m2/day orally
Trial: 3884152
Drug: 100 mg/m2/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/m2/day iv
Trial: 3884152
Drug: Oral VP‐16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral VP‐16
Trial: 24392497
Drug: Anesthetic mouthwash
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthetic mouthwash along with oral analgesic post biopsy (Group B)
Trial: 24392497
Drug: No analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No analgesic post biopsy, except when required (Group A)
Trial: 17970786
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy (HDC) with cyclophosphamide and thiotepa after six courses of cyclophosphamide, doxorubicin, and 5-fluorouracil followed by tamoxifen.
Trial: 17970786
Drug: Standard-dose (STD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (STD) chemotherapy with six courses of cyclophosphamide, doxorubicin, and 5-fluorouracil followed by tamoxifen.
Trial: 17970786
Drug: Standard-dose (STD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (STD) chemotherapy
Trial: 15997634
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg bid (group 1)
Trial: 15997634
Drug: Enalapril 5
RxNorm normalized name: enalapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5 mg bid + nitrendipine 20 mg qd (group 2)
Trial: 15997634
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (enalapril + nitrendipine)
Trial: 15997634
Drug: Monotherapy (enalapril)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (enalapril)
Trial: 2054268
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg as enteric coated granules administered alone
Trial: 2054268
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg as enteric coated granules administered after ranitidine 300 mg
Trial: 29778344
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care with pharmacist intervention (medication reconciliation, medication review, participation in ward rounds)
Trial: 27648957
Drug: Ordered mesoporous
RxNorm normalized name: Orderable Drug Form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordered mesoporous silica formulation of fenofibrate
Trial: 24613691
Drug: PVS‐10200 (low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PVS‐10200 (low-dose cohort A)
Trial: 24613691
Drug: PVS‐10200 (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PVS‐10200 (high-dose cohort B)
Trial: 17389731
Drug: Low serum
RxNorm normalized name: ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Sunceutical SPF 50 Mineral Glow Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low serum digoxin concentrations (SDC) (0.5-0.9 ng/mL)
Trial: 17389731
Drug: High serum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High serum digoxin concentrations (SDC) (≥ 1 ng/mL)